Cookson Peirce & CO Inc Merck & Co., Inc. Transaction History

Cookson Peirce & CO Inc

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$123.8 - $132.96 $6.26 Million - $6.73 Million	50,595 Added 10.79%	519,568 $64.3 Million
Q1 2024 Apr 23, 2024	SELL	$113.24 - $131.95 $309,145 - $360,223	-2,730 Reduced 0.58%	468,973 $61.9 Million
Q4 2023 Jan 30, 2024	SELL	$100.18 - $109.02 $1.16 Million - $1.26 Million	-11,574 Reduced 2.39%	471,703 $51.4 Million
Q3 2023 Nov 07, 2023	BUY	$102.95 - $114.33 $560,665 - $622,641	5,446 Added 1.14%	483,277 $49.8 Million
Q2 2023 Aug 01, 2023	SELL	$108.61 - $118.38 $982,703 - $1.07 Million	-9,048 Reduced 1.86%	477,831 $55.1 Million
Q1 2023 May 03, 2023	BUY	$102.94 - $114.86 $618,875 - $690,538	6,012 Added 1.25%	486,879 $51.8 Million
Q4 2022 Jan 31, 2023	BUY	$87.44 - $112.11 $27.3 Million - $35 Million	311,855 Added 184.52%	480,867 $53.3 Million
Q3 2022 Nov 08, 2022	BUY	$84.53 - $94.96 $128,485 - $144,339	1,520 Added 0.91%	169,012 $14.6 Million
Q2 2022 Jul 20, 2022	BUY	$83.49 - $94.64 $14 Million - $15.9 Million	167,492 New	167,492 $15.3 Million
Q1 2020 May 04, 2020	SELL	$63.36 - $87.82 $315,279 - $436,992	-4,976 Closed	0 $0
Q4 2019 Jan 27, 2020	SELL	$77.58 - $87.54 $2,249 - $2,538	-29 Reduced 0.58%	4,976 $431,000
Q3 2019 Nov 05, 2019	BUY	$76.08 - $82.93 $17,498 - $19,073	230 Added 4.82%	5,005 $402,000
Q2 2019 Jul 31, 2019	SELL	$69.84 - $81.59 $39,110 - $45,690	-560 Reduced 10.5%	4,775 $0
Q1 2019 May 01, 2019	BUY	$69.58 - $79.36 $37,573 - $42,854	540 Added 11.26%	5,335 $444,000
Q4 2018 Feb 07, 2019	BUY	$65.24 - $75.71 $312,825 - $363,029	4,795 New	4,795 $349,000

3,820

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Cookson Peirce & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Cookson Peirce & CO Inc with notifications on news.